Genprex Inc (GNPX) FinancialsGNPXFinancialGenprex Inc

Evaluating the bottom line, Genprex Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -203.86%, provide a clear picture of how effectively GNPX converts its operational activities into shareholder value.

In the context of the broader market, GNPX competes directly with industry leaders such as ARTL and MTNB. With a market capitalization of $3.54M, it holds a significant position in the sector. When comparing efficiency, GNPX's gross margin of N/A stands against ARTL's N/A and MTNB's N/A. Such benchmarking helps identify whether Genprex Inc is trading at a premium or discount relative to its financial performance.

Genprex has consistently reported negative net income, with the latest figure at -4,467,219 USD for Q2 2026. The EPS has been negative, with a recent figure of -9.40, indicating ongoing losses.